Beranda › Gatal
Uji klinis Gatal yang merekrut di AS
15 studi untuk Gatal merekrut peserta di lokasi di seluruh Amerika Serikat.
Kota dengan studi terbanyak
Berdasarkan negara bagian
Studi yang baru diperbarui
Teks studi resmi (Bahasa Inggris)
Cervical Traction to Reduce Gabaergic Medication Use for Neuropathic Itch
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT06751056Efficacy and Safety Study to Evaluate SD-101 in Epidermolysis Bullosa
Menerima pesertaFase 3
28 Days – 12 Years · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT07482787A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
Menerima pesertaFase 3
Usia 12 hingga 17 · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT06979453Cardamom and Topical Roseomonas in Atopic Dermatitis
Menerima pesertaFase 2
Usia 2 hingga 100 · Semua jenis kelamin · Diperbarui 13 Agu 2026 · NCT06096857Obtaining Descriptive Classifications of Pruritus and Assessing Change in Pruritus Over Time in Atopic Dermatitis Patients Using Topical Roflumilast Cream.
Menerima pesertaFase 4
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 13 Agu 2026 · NCT07560618Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)
Menerima pesertaFase 3
Usia 18 hingga 90 · Semua jenis kelamin · Diperbarui 6 Jul 2026 · NCT05263206TriCalm Hydrogel® in the Treatment of Immunotherapy-Related Pruritus
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Jun 2026 · NCT06748404A Study to Learn About Ritlecitinib for the Potential Treatment of Chronic Spontaneous Urticaria in Adults.
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Jun 2026 · NCT07219615Repurposing Dupilumab for Management of Pruritic Genetic Inflammatory Skin Disorders
Menerima pesertaFase awal 1
6 Months · Semua jenis kelamin · Diperbarui 1 Mei 2026 · NCT05649098VR-PMR for Post-Burn Symptoms
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Mar 2026 · NCT07317271Study to Compare Maternal, Fetal, and Infant Outcomes of Women With Mild to Moderate Atopic Dermatitis Exposed to Ruxolitinib Cream During Pregnancy With an Unexposed Control Population
Menerima pesertaStudi observasional
Usia 15 hingga 50 · Wanita · Diperbarui 11 Des 2025 · NCT06259669An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis Exposed to Ruxolitinib Cream Versus Topical Corticosteroids During Pregnancy: A US Claims Database Analysis
Menerima pesertaStudi observasional
Usia 14 ke atas · Wanita · Diperbarui 11 Des 2025 · NCT06627335A Study to Assess the Safety and Efficacy of LB-P8 in Patients With PSC
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 24 Okt 2025 · NCT06699121Novel Strategies for Reducing Burn Scar Itch
Menerima pesertaFase 3
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 24 Sep 2025 · NCT06801626Dupixent in Adults With Refractory Post-Burn Pruritus in an Ambulatory Clinic
Menerima pesertaFase 2
Usia 18 hingga 60 · Semua jenis kelamin · Diperbarui 19 Sep 2025 · NCT06226610Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.